Ana M Cuevas-Toro, Carmen Díaz-Batanero, María Del Mar Sánchez-Fuentes
{"title":"纤维肌痛女性的性欲：超越疼痛？","authors":"Ana M Cuevas-Toro, Carmen Díaz-Batanero, María Del Mar Sánchez-Fuentes","doi":"10.1093/jsxmed/qdaf123","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Women with fibromyalgia often experience sexual dysfunction, particularly reduced sexual desire, but few studies have used specific measures, such as the Sexual Desire Inventory, to assess this, and the predictors of sexual desire in these women remain unclear.</p><p><strong>Aim: </strong>This study aimed to analyze sexual desire in Spanish women diagnosed with fibromyalgia (fibromyalgia group, FG) and in a control group (CG) of healthy women and to examine the predictors (age, symptoms duration, time since diagnosis, severity of fibromyalgia, antidepressant drugs, depressive symptoms and anxiety symptoms) of sexual desire in the FG.</p><p><strong>Methods: </strong>The sample consisted of 81 women divided into 2 groups FG (n = 46) and CG (n = 35). The average age was 47.23 years (SD = 9.22) for the FG and 46.14 years (SD = 9.52) for the CG.</p><p><strong>Outcomes: </strong>The main outcome measures were sexual desire, as assessed through the Sexual Desire Inventory, severity of fibromyalgia (Fibromyalgia Impact Questionnaire) and anxiety and depression (Hospital Anxiety and Depression Scale).</p><p><strong>Results: </strong>Women in the FG had lower sexual desire than those in the CG. Age, time since diagnosis, and depression were associated with different dimensions of sexual desire. In contrast, fibromyalgia severity, anxiety, and months using SSRIs were not linked to any dimensions of sexual desire. Hierarchical multiple regression analysis revealed that age, time since of FM diagnosis, and depression predicted global sexual desire, accounting for 30% of its variance.</p><p><strong>Clinical implications: </strong>Assessing sexual desire and addressing depressive symptoms early in women with fibromyalgia is essential for improving their sexual health.</p><p><strong>Strengths and limitations: </strong>This is the first study to assess different dimensions of sexual desire, including sexual desire for an attractive person, while simultaneously examining key factors associated with sexual desire in women with fibromyalgia. However, the sample size is relatively small, and the study lacks a longitudinal design.</p><p><strong>Conclusion: </strong>Women with FG have lower sexual desire than healthy women, primarily due to age, time since diagnosis, and depressive symptoms.</p>","PeriodicalId":51100,"journal":{"name":"Journal of Sexual Medicine","volume":" ","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2025-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Sexual desire in women with fibromyalgia: beyond the pain?\",\"authors\":\"Ana M Cuevas-Toro, Carmen Díaz-Batanero, María Del Mar Sánchez-Fuentes\",\"doi\":\"10.1093/jsxmed/qdaf123\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Women with fibromyalgia often experience sexual dysfunction, particularly reduced sexual desire, but few studies have used specific measures, such as the Sexual Desire Inventory, to assess this, and the predictors of sexual desire in these women remain unclear.</p><p><strong>Aim: </strong>This study aimed to analyze sexual desire in Spanish women diagnosed with fibromyalgia (fibromyalgia group, FG) and in a control group (CG) of healthy women and to examine the predictors (age, symptoms duration, time since diagnosis, severity of fibromyalgia, antidepressant drugs, depressive symptoms and anxiety symptoms) of sexual desire in the FG.</p><p><strong>Methods: </strong>The sample consisted of 81 women divided into 2 groups FG (n = 46) and CG (n = 35). The average age was 47.23 years (SD = 9.22) for the FG and 46.14 years (SD = 9.52) for the CG.</p><p><strong>Outcomes: </strong>The main outcome measures were sexual desire, as assessed through the Sexual Desire Inventory, severity of fibromyalgia (Fibromyalgia Impact Questionnaire) and anxiety and depression (Hospital Anxiety and Depression Scale).</p><p><strong>Results: </strong>Women in the FG had lower sexual desire than those in the CG. Age, time since diagnosis, and depression were associated with different dimensions of sexual desire. In contrast, fibromyalgia severity, anxiety, and months using SSRIs were not linked to any dimensions of sexual desire. Hierarchical multiple regression analysis revealed that age, time since of FM diagnosis, and depression predicted global sexual desire, accounting for 30% of its variance.</p><p><strong>Clinical implications: </strong>Assessing sexual desire and addressing depressive symptoms early in women with fibromyalgia is essential for improving their sexual health.</p><p><strong>Strengths and limitations: </strong>This is the first study to assess different dimensions of sexual desire, including sexual desire for an attractive person, while simultaneously examining key factors associated with sexual desire in women with fibromyalgia. However, the sample size is relatively small, and the study lacks a longitudinal design.</p><p><strong>Conclusion: </strong>Women with FG have lower sexual desire than healthy women, primarily due to age, time since diagnosis, and depressive symptoms.</p>\",\"PeriodicalId\":51100,\"journal\":{\"name\":\"Journal of Sexual Medicine\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2025-05-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Sexual Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/jsxmed/qdaf123\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Sexual Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/jsxmed/qdaf123","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
Sexual desire in women with fibromyalgia: beyond the pain?
Background: Women with fibromyalgia often experience sexual dysfunction, particularly reduced sexual desire, but few studies have used specific measures, such as the Sexual Desire Inventory, to assess this, and the predictors of sexual desire in these women remain unclear.
Aim: This study aimed to analyze sexual desire in Spanish women diagnosed with fibromyalgia (fibromyalgia group, FG) and in a control group (CG) of healthy women and to examine the predictors (age, symptoms duration, time since diagnosis, severity of fibromyalgia, antidepressant drugs, depressive symptoms and anxiety symptoms) of sexual desire in the FG.
Methods: The sample consisted of 81 women divided into 2 groups FG (n = 46) and CG (n = 35). The average age was 47.23 years (SD = 9.22) for the FG and 46.14 years (SD = 9.52) for the CG.
Outcomes: The main outcome measures were sexual desire, as assessed through the Sexual Desire Inventory, severity of fibromyalgia (Fibromyalgia Impact Questionnaire) and anxiety and depression (Hospital Anxiety and Depression Scale).
Results: Women in the FG had lower sexual desire than those in the CG. Age, time since diagnosis, and depression were associated with different dimensions of sexual desire. In contrast, fibromyalgia severity, anxiety, and months using SSRIs were not linked to any dimensions of sexual desire. Hierarchical multiple regression analysis revealed that age, time since of FM diagnosis, and depression predicted global sexual desire, accounting for 30% of its variance.
Clinical implications: Assessing sexual desire and addressing depressive symptoms early in women with fibromyalgia is essential for improving their sexual health.
Strengths and limitations: This is the first study to assess different dimensions of sexual desire, including sexual desire for an attractive person, while simultaneously examining key factors associated with sexual desire in women with fibromyalgia. However, the sample size is relatively small, and the study lacks a longitudinal design.
Conclusion: Women with FG have lower sexual desire than healthy women, primarily due to age, time since diagnosis, and depressive symptoms.
期刊介绍：
The Journal of Sexual Medicine publishes multidisciplinary basic science and clinical research to define and understand the scientific basis of male, female, and couples sexual function and dysfunction. As an official journal of the International Society for Sexual Medicine and the International Society for the Study of Women''s Sexual Health, it provides healthcare professionals in sexual medicine with essential educational content and promotes the exchange of scientific information generated from experimental and clinical research.
The Journal of Sexual Medicine includes basic science and clinical research studies in the psychologic and biologic aspects of male, female, and couples sexual function and dysfunction, and highlights new observations and research, results with innovative treatments and all other topics relevant to clinical sexual medicine.
The objective of The Journal of Sexual Medicine is to serve as an interdisciplinary forum to integrate the exchange among disciplines concerned with the whole field of human sexuality. The journal accomplishes this objective by publishing original articles, as well as other scientific and educational documents that support the mission of the International Society for Sexual Medicine.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
